Literature DB >> 31888823

Retinoic acid grafted to hyaluronan for skin delivery: Synthesis, stability studies, and biological evaluation.

Gloria Huerta-Ángeles1, Martina Brandejsová2, Petr Štěpán2, Vojtěch Pavlík3, Jana Starigazdová2, Paulina Orzol2, Kateřina Kopecká2, Pavlína Halamková2, Jaromír Kulhánek2, Vladimír Velebný2.   

Abstract

All-trans retinoic acid (ATRA) was grafted to hyaluronan (HA) via esterification. The reaction was mediated by mixed anhydrides. A perfect control of the degree of substitution (0.5-7.5%) was obtained by varying the molar ratio of retinoic acid in the feed. The degree of substitution plays a significant role in the long-term stability. The photodegradation of HA-ATRA upon UVA irradiation resulted in β-ionone, β-cyclocitral and 5,6-epoxy-(E)-retinoic acid. The photostability of the conjugate had increased with the combination with morin. The chemical structure of HA-ATRA and its degradation products was elucidated using NMR spectroscopy, SEC-MALLS, and gas chromatography-mass spectrometry (GC-MS). ATRA did not loss its biological activity after conjugation, as demonstrated by gene expression. The derivative was able to penetrate across the stratum corneum. Besides, HA-ATRA downregulated the expression of anti-inflammatory interleukins 6 and 8. HA-ATRA would be expected to be used for transdermal drug delivery or cosmetics.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  (±)-6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (trolox, PubChem CID: 40634); 2-Ethylhexyl 2-cyano-3,3-diphenylacrylate (PubChem CID: 22571); 2-Ethylhexyl 4-methoxycinnamate (PubChem CID: 21630); Antioxidants; Avobenzone (1-(4-Methoxyphenyl)-3-(4-tert-butylphenyl)-1,3-propanedione, CID: 51040); Butylated hydroxyanisole (BHA, PubChem CID: 517036); Butylated hydroxytoluene (BHT, PubChem CID: 31404); Hyaluronic acid (PubChem CID: 24728612); Morin hydrate (2′,3,4′,5,7-Pentahydroxyflavone, PubChem CID: 16219651); Retinoic acid (PubChem CID: 444795); Retinoids; Retinyl palmitate (PubChem CID: 5280531); Skin; hyaluronan

Mesh:

Substances:

Year:  2019        PMID: 31888823     DOI: 10.1016/j.carbpol.2019.115733

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  4 in total

1.  Retinoic Acid Grafted to Hyaluronic Acid Activates Retinoid Gene Expression and Removes Cholesterol from Cellular Membranes.

Authors:  Vojtěch Pavlík; Veronika Machalová; Martin Čepa; Romana Šínová; Barbora Šafránková; Jaromír Kulhánek; Tomáš Drmota; Lukáš Kubala; Gloria Huerta-Ángeles; Vladimír Velebný; Kristina Nešporová
Journal:  Biomolecules       Date:  2022-01-25

Review 2.  Polysaccharide-based nanomedicines for cancer immunotherapy: A review.

Authors:  Yujun Zeng; Yufan Xiang; Ruilong Sheng; Helena Tomás; João Rodrigues; Zhongwei Gu; Hu Zhang; Qiyong Gong; Kui Luo
Journal:  Bioact Mater       Date:  2021-03-18

Review 3.  Versatile Use of Chitosan and Hyaluronan in Medicine.

Authors:  Katarína Valachová; Ladislav Šoltés
Journal:  Molecules       Date:  2021-02-23       Impact factor: 4.411

4.  Synergistic Effect of L-Carnosine and Hyaluronic Acid in Their Covalent Conjugates on the Antioxidant Abilities and the Mutual Defense against Enzymatic Degradation.

Authors:  Valeria Lanza; Valentina Greco; Eleonora Bocchieri; Sebastiano Sciuto; Rosanna Inturri; Luciano Messina; Susanna Vaccaro; Francesco Bellia; Enrico Rizzarelli
Journal:  Antioxidants (Basel)       Date:  2022-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.